The cost‐effectiveness of dapagliflozin compared to DPP‐4 inhibitors in the treatment of type 2 diabetes mellitus in the Netherlands

por Van der Linden, N., Van Olst, S., Nekeman, S., Uyl‐de Groot, C.A.
Publicado 2020

Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line t...

por De Groot, S., Blommestein, H. M., Redekop, W. K., Sleijfer, S., Kiemeney, L. A. L. M., Oosterwijk, E., Uyl-de Groot, C. A.
Publicado 2017

Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma

por de Groot, S., Redekop, W. K., Versteegh, M. M., Sleijfer, S., Oosterwijk, E., Kiemeney, L. A. L. M., Uyl-de Groot, C. A.
Publicado 2017

Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry

por De Groot, S., Sleijfer, S., Redekop, W. K., Oosterwijk, E., Haanen, J. B. A. G., Kiemeney, L. A. L. M., Uyl-de Groot, C. A.
Publicado 2016

Cost-effectiveness of adjuvant systemic therapies for patients with high-risk melanoma in Europe: a model-based economic evaluation

por Mulder, E.E.A.P., Smit, L., Grünhagen, D.J., Verhoef, C., Sleijfer, S., van der Veldt, A.A.M., Uyl-de Groot, C.A.
Publicado 2021

Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer – the SONIA study: study protocol for a randomized controlled trial

por van Ommen-Nijhof, A., Konings, I. R., van Zeijl, C. J. J., Uyl-de Groot, C. A., van der Noort, V., Jager, A., Sonke, G. S.
Publicado 2018

Developing a decision tool to identify patients with personality disorders in need of highly specialized care

por Goorden, M., Willemsen, E. M. C., Bouwmans-Frijters, C. A. M., Busschbach, J. J. V., Noomx, M. J., van der Feltz-Cornelis, C. M., Uyl-de Groot, C. A., Hakkaart-van Roijen, L.
Publicado 2017

Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study

por Holtzer-Goor, K. M., Schaafsma, M. R., Joosten, P., Posthuma, E. F. M., Wittebol, S., Huijgens, P. C., Mattijssen, E. J. M., Vreugdenhil, G., Visser, H., Peters, W. G., Erjavec, Z., Wijermans, P. W., Daenen, S. M. G. J., van der Hem, K. G., van Oers, M. H. J., Uyl-de Groot, C. A.
Publicado 2015

Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens

por Oosten, L. E. M., Chamuleau, M. E. D., Thielen, F. W., de Wreede, L. C., Siemes, C., Doorduijn, J. K., Smeekes, O. S., Kersten, M. J., Hardi, L., Baars, J. W., Demandt, A. M. P., Stevens, W. B. C., Nijland, M., van Imhoff, G. W., Brouwer, R., Uyl-de Groot, C. A., Kluin, P. M., de Jong, D., Veelken, H.
Publicado 2017

Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs

por Franken, M.G., Leeneman, B., Aarts, M.J.B., van Akkooi, A.C.J., van den Berkmortel, F.W.P.J., Boers-Sonderen, M.J., van den Eertwegh, A.J.M., de Groot, J.W.B., Hospers, G.A.P., Kapiteijn, E., Piersma, D., van Rijn, R.S., Suijkerbuijk, K.P.M., van der Veldt, A.A.M., Westgeest, H.M., Wouters, M.W.J.M., Haanen, J.B.A.G., Uyl-de Groot, C.A.
Publicado 2021